From: Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
Urologist characteristics | ADT use by era | ||||
---|---|---|---|---|---|
a2000-2002 | a2004-2007 | ||||
Odds ratio | 95% CI | Odds ratio | 95% CI | p-value interaction with era | |
Years in practice (per 5 years) | 1.01 | (0.97, 1.05) | 1.03 | (1.00 ,1.07) | 0.47 |
Board certification | |||||
Yes | ref | ref | |||
No | 1.01 | (0.82, 1.24) | 1.06 | (0.89, 1.28) | 0.94 |
Academic affiliation | |||||
Major or minor | ref | ref | |||
None | 1.32 | (1.17, 1.56) | 1.34 | (1.15, 1.56) | 0.68 |
Patient panel size | |||||
<14 | ref | ref | 0.13 | ||
14 - 44 | 1.02 | (0.84, 1.25) | 0.93 | (0.77, 1.12) | |
45 - 74 | 1.23 | (0.99, 1.54) | 1.03 | (0.84, 1.26) | |
≥75 | 1.10 | (0.86, 1.40) | 0.89 | (0.71, 1.11) |